Related Experiment Videos
Role of antibiotics in meconium aspiration syndrome
Sriparna Basu1, Ashok Kumar, B D Bhatia
1Division of Neonatology, Department of Paediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. drsriparnabasu@rediffmail.com
Background:
Meconium aspiration syndrome (MAS) is a major cause of severe respiratory distress in newborns and the role of antibiotics in its management is not well defined.
Objective:
To determine the role of routine antibiotic therapy in the management of MAS.
Methods:
After excluding the possibility of sepsis, 144 patients with MAS were randomised into two groups. Group A (study group) received ampicillin and gentamicin for 7 days, commencing between 24 and 36 hours of life, and group B, the controls, received no antibiotics. Both groups received similar supportive management. The primary outcome measure was the development of infection. Details of clinical progress during hospitalisation were recorded. All were followed up for a minimum of 3 months.
Results:
The patient profiles were similar in both groups. Five patients (three in the study group, two controls) developed culture-positive sepsis during their hospital stay. No significant difference was detected between the groups regarding period of oxygen dependency (5.8 vs 5.9 days), day of starting feeds (4.0 vs 4.2), day of achievement of full feeds (9.4 vs 9.3), clearance of chest radiograph (11.7 vs 12.9 days) or duration of hospital stay (13.7 vs 13.5 days). The most common radiological features were parenchymal infiltrates followed by hyperinflation. The incidence of complications was similar in both groups.
Conclusion:
Routine antibiotic therapy is not necessary for managing MAS.
Insights
Routine antibiotic therapy is not necessary for managing meconium aspiration syndrome (MAS). This study found no significant differences in infection rates or clinical outcomes between newborns with MAS who received antibiotics and those who did not.
Area of Science:
- Neonatal care
- Pediatric pulmonology
- Infectious disease management
Background:
- Meconium aspiration syndrome (MAS) is a leading cause of severe newborn respiratory distress.
- The established role of antibiotic use in MAS management remains unclear.
Purpose of the Study:
- To investigate the necessity of routine antibiotic administration in managing MAS.
- To compare clinical outcomes in MAS patients with and without antibiotic treatment.
Main Methods:
- A randomized controlled trial involving 144 newborns diagnosed with MAS after sepsis exclusion.
- Study group received ampicillin and gentamicin for 7 days; control group received no antibiotics.
- Both groups received comparable supportive care, with infection development as the primary outcome measure and follow-up for 3 months.
Main Results:
- No significant differences were observed between the antibiotic and control groups in oxygen dependency, feeding progression, or radiographic clearance.
- Sepsis developed in 3 patients in the antibiotic group and 2 in the control group.
- Hospital stay duration and complication incidence were similar across both groups.
Conclusions:
- Routine antibiotic therapy is not indicated for the management of meconium aspiration syndrome.
- Current evidence does not support the use of antibiotics in MAS cases without confirmed sepsis.
Related Concept Videos
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Urine Studies II: Urine Culture and Sensitivity Test